<DOC>
	<DOCNO>NCT00842023</DOCNO>
	<brief_summary>The purpose study determine whether Nesiritide effective nitroglycerin modify inflammatory neurohormonal biomarkers without renal toxicity proper infusion duration administer .</brief_summary>
	<brief_title>Assessment Biomarkers Cardiorenal Syndrome Acute Decompensated Heart Failure With Vasodilator Therapy</brief_title>
	<detailed_description>No additional detail provide</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardio-Renal Syndrome</mesh_term>
	<mesh_term>Nitroglycerin</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>At least 18 year age . Subject must able understand potential risk benefit associate study . Baseline systolic blood pressure â‰¥ 90 mm Hg time enrollment . Clinical symptom dyspnea laboratory admission BNP level &gt; 500 pg/mL . Neither pregnant breastfeeding time enrollment . Authorization patient 's enrollment patient 's medical provider . &lt; 18 year age Denies write informed consent Pregnant lactating . Baseline systolic BP &lt; 90 mmHg cardiogenic shock No symptom congestion admission BNP &lt; 500 pg/mL Known allergy E.coliderived product , history anaphylactic reaction nesiritide . Receiving dialysis time enrollment . Serum creatinine &gt; 2.5 mg/dL time enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Natriuretic peptide</keyword>
	<keyword>BNP</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Nitoglycerin</keyword>
	<keyword>Biomarkers</keyword>
</DOC>